EP0993270B1 - Gerät und verfahren zur beurteilung von neuromuskulärer funktion - Google Patents

Gerät und verfahren zur beurteilung von neuromuskulärer funktion Download PDF

Info

Publication number
EP0993270B1
EP0993270B1 EP98931451A EP98931451A EP0993270B1 EP 0993270 B1 EP0993270 B1 EP 0993270B1 EP 98931451 A EP98931451 A EP 98931451A EP 98931451 A EP98931451 A EP 98931451A EP 0993270 B1 EP0993270 B1 EP 0993270B1
Authority
EP
European Patent Office
Prior art keywords
electrode
stimulus
wrist
detection
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP98931451A
Other languages
English (en)
French (fr)
Other versions
EP0993270A1 (de
Inventor
Shai N. Gozani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neumetrix Inc
Neurometrix Inc
Original Assignee
Neumetrix Inc
Neurometrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neumetrix Inc, Neurometrix Inc filed Critical Neumetrix Inc
Publication of EP0993270A1 publication Critical patent/EP0993270A1/de
Application granted granted Critical
Publication of EP0993270B1 publication Critical patent/EP0993270B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1104—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb induced by stimuli or drugs
    • A61B5/1106—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb induced by stimuli or drugs to assess neuromuscular blockade, e.g. to estimate depth of anaesthesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/389—Electromyography [EMG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/389—Electromyography [EMG]
    • A61B5/395—Details of stimulation, e.g. nerve stimulation to elicit EMG response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
    • A61B5/4041—Evaluating nerves condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2505/00—Evaluating, monitoring or diagnosing in the context of a particular type of medical care
    • A61B2505/05—Surgical care
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6824—Arm or wrist
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6825—Hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A61B5/7217—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise originating from a therapeutic or surgical apparatus, e.g. from a pacemaker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives

Definitions

  • the invention relates to apparatus and methods for assessment of neuromuscular function. More specifically, the invention relates to apparatus and methods for diagnosing peripheral nerve and muscle pathologies based on assessments of neuromuscular function.
  • Neuromuscular disorders such as, for example, Carpal Tunnel Syndrome (CTS)
  • CTS Carpal Tunnel Syndrome
  • CTS is one of the most common forms of neuromuscular disease. The disease is thought to arise from compression of the Median nerve as it traverses the wrist. CTS often causes discomfort or loss of sensation in the hand, and, in severe cases, a nearly complete inability to use one's hands. Highly repetitive wrist movements, as well as certain medical conditions, such as, for example, diabetes, rheumatoid arthritis, thyroid disease, and pregnancy, are thought to be factors that contribute to the onset of CTS. In 1995, the US National Center for Health Statistics estimated that there were over 1.89 million cases of CTS in the United States alone.
  • Rosier U.S. Pat. No. 4,807,643
  • This instrument has, however, several very important disadvantages.
  • Second, the Rosier apparatus suffers from the disadvantage that it is not automated. In particular, it demands that the user of the device establish the magnitude of the electrical stimulus, as well as a response detection threshold.
  • the apparatus of the present invention is as claimed in claim 1.
  • the method of the present invention is as claim 7.
  • Optional features are recited in the dependent claims.
  • apparatus and methods are provided for the substantially automated, rapid, and efficient assessment of neuromuscular function without the involvement of highly trained personnel.
  • Assessment of neuromuscular function occurs by stimulating a nerve, then measuring the response of a muscle innervated by that nerve.
  • the muscle response is detected by measuring the myoelectric potential generated by the muscle in response to the stimulus.
  • One indication of the physiological state of the nerve is provided by the delay between application of a stimulus and detection of a muscular response. If the nerve is damaged, conduction of the signal via the nerve to the muscle, and, hence, detection of the muscle's response, will be slower than in a healthy nerve. An abnormally high delay between stimulus application and detection of muscle response indicates, therefore, impaired neuromuscular function.
  • both the application of stimulus and the detection of responses is carried out entirely at a position that is immediately proximal to the wrist of an individual (i.e., the wrist crease).
  • This anatomical location is familiar and easy to locate, thus ensuring correct placement of the apparatus at the assessment site by non-experts while still maintaining the accuracy of results.
  • This ease of use increases the availability and decreases the cost of diagnosing pathologies such as Carpal Tunnel Syndrome (CTS).
  • CTS Carpal Tunnel Syndrome
  • Apparatus and methods of the invention assess neuromuscular function in the arm of an individual by using a stimulator to apply a stimulus to a nerve that traverses the wrist of the individual.
  • the stimulator is adapted for applying the stimulus to the nerve at a position which is proximal to the wrist of the individual.
  • the stimulus may be, for example, an electrical stimulus or a magnetic stimulus. Other types of stimuli may be used.
  • a detector adapted for detecting the myoelectric potential generated by a muscle in response to the stimulus, detects the response of the muscle to the stimulus at a site that is also proximal to the wrist of the individual.
  • a controller evaluates the physiological function of the nerve by, for example, determining a delay between application of stimulus and detection of myoelectic potential. The delay is then correlated to the presence or absence of a neuromuscular pathology, such as, for example, Carpal Tunnel Syndrome (CTS).
  • CTS Carpal Tunnel Syndrome
  • the stimulator and the detector are both in electrical communication with electrodes adapted for placement on the arm of an individual proximal to the wrist.
  • the controller may also be in electrical communication with a reference electrode and a temperature sensor.
  • An apparatus of the invention may further comprise a communications port for establishing communication between the apparatus and an external device, such as, for example, a personal computer.
  • an apparatus of the invention further comprises an indicator.
  • the indicator is in electrical communication with the controller and is adapted for indicating the physiological function evaluated by the controller in response to the stimulus applied and myoelectic potential detected.
  • the indicator may comprise a light emitting diode.
  • the indicator is adapted for indicating the presence or absence of CTS.
  • An apparatus of the invention may be further embodied in an electrode configuration contained in an electrode housing for releasably securing to the wrist of an individual.
  • the electrode housing contains an attachment mechanism, such as, for example, a non-irritating adhesive material, for securing to the arm of the individual and may be disposable.
  • the electrode housing preferably has a connector for electrical communication with an apparatus comprising a stimulator, a detector, and a processor, as described above.
  • the electrode housing comprises stimulation and detection electrodes.
  • the stimulation and detection electrodes are sized and shaped in the housing so that they contact an anterior aspect of an arm of the individual proximal to the wrist, when the housing is secured to the wrist of the individual.
  • the electrode configuration may further contain a temperature sensor and/or a reference electrode.
  • the electrode configuration comprises a second stimulation electrode and a second detection electrode.
  • the two stimulation electrodes are positioned substantially in the center of the electrode housing and are arranged so that they are positioned at opposite ends of the housing.
  • the two stimulation electrodes are preferably arranged so that, when the housing is placed on the anterior aspect of an arm of a user, one of the stimulation electrodes is located immediately proximal to the wrist and the other at a location more proximal from the wrist.
  • the two detection electrodes are also located at opposite ends of the housing, but they are positioned such that, when placed on the anterior aspect of an arm of a user, one detection electrode is located on the medial, and the other on the lateral, side of the wrist.
  • Methods of the invention relate to the assessment of neuromuscular function using an apparatus of the invention.
  • a stimulus is applied to a nerve that traverses the wrist of an individual proximal to the wrist.
  • a muscle innervated by the nerve responds and thereby generates a myoelectric potential, which is detected proximal to the wrist of the individual.
  • the detected response is processed by determining a first derivative of the myoelectric potential and, preferably, a second derivative of the myoelectric potential.
  • these derivatives are used to determine an appropriate stimulation level, as well as to determine the delay between application of stimuli and detection of the associated responses.
  • additional measurements related to the delay are taken. For example, changes in the delay induced by application of at least two stimulus applications is determined. The delay and associated parameters calculated from any of the measurements are then correlated to a physiological function of the nerve and muscle.
  • an apparatus of the invention is used to indicate the presence or absence of CTS.
  • a plurality of stimuli are applied to a nerve passing through the carpal tunnel, such as, for example, the Median nerve.
  • the stimuli may be delivered one at a time at a predetermined rate or they may be delivered in pairs at a predetermined rate. If delivered in pairs, the application of stimuli is separated by a predetermined time interval.
  • a plurality of myoelectric potentials are generated by a muscle innervated by the stimulated nerve in response to the stimuli.
  • Each myoelectic potential is generated in response to a respective stimulus application.
  • a delay for each of said stimulus applications and detected responses is determined.
  • Statistics such as, for example, mean and standard deviation, are calculated for the plurality of delays. The probable value that the individual has CTS is calculated based on these statistics. An indication of the presence or absence of CTS is then given based on that value.
  • the method may involve further steps.
  • the method relates to calculating the difference between delays measured in response to two stimuli delivered at short temporal intervals, and determining the probable value that an individual has CTS based on these delay differences and calculated statistics, as described above.
  • a level of noise is measured prior to stimulating the nerve.
  • the mean and standard deviation of the delays is adjusted relative to the skin temperature.
  • the apparatus and methods of the invention allow for the less costly and more readily available detection of neuromuscular pathologies, such as, for example, CTS, without the aid of a skilled professional.
  • FIG. 1 An illustrative embodiment of an apparatus of the invention and its placement on the users forearm 8 is shown in FIG. 1.
  • the invention consists of two major components: a neuromuscular electrode 1 and an electronic monitor 2.
  • the neuromuscular electrode 1 includes both a stimulator and a detector.
  • the electronic monitor 2 includes both a controller and an indicator.
  • the neuromuscular electrode 1 and electronic monitor 2 are physically separable with electrical connections between the two components established by physical contact between a connector 6, associated with the neuromuscular electrode 1 and connector slot 7 associated with the electronic monitor 2.
  • neuromuscular electrode 1 and electronic monitor 2 constitute a single, physically inseparable unit.
  • the electronic monitor 2 contains means to actuate the diagnostic process. Referring to the illustrative embodiment shown in FIG.
  • a push-button 3 is provided to initiate said diagnostic process.
  • the electronic monitor 2 also contains an indicator to display or convey the results of the diagnostic process.
  • an indicator includes a display 4, which includes two multi-segment light-emitting diodes (LEDs) and which provides feedback and results.
  • LEDs multi-segment light-emitting diodes
  • Other indicators may be used, including, but not limited to, single and multicolor discrete LEDs.
  • Other types of indicators, such as, for example, speakers, may provide auditory signals.
  • the electronic monitor 2 also contains a communications port to connect and communicate with external devices. Referring to the illustrative embodiment shown in FIG. 1, the communications port includes a jack 5 into which a cable may be inserted. The other end of the cable is then connected to any number of different devices, including, but not limited to, computers and telephone lines.
  • the neuromuscular electrode 1 delivers electrical stimuli to the skin surface, detects biopotentials from the skin surface and measures additional physiological and biological parameters, such as, for example, skin temperature.
  • the neuromuscular electrode 1 is placed on the anterior aspect of the forearm 8 immediately proximal to the wrist crease 9.
  • the physical dimensions of the neuromuscular electrode 1 are chosen from a predetermined set of dimensions which are optimized for the range of wrist sizes found in adults.
  • the electrodes may be configured in a small, regular and large size.
  • Additional embodiments are contemplated in which the neuromuscular electrode 1 includes means to vary its physical dimensions over a predetermined range, such as, for example, being contained in an electrode housing, such as, an adjustable band or strap.
  • the band or strap may also be detachable.
  • FIG. 2A An illustrative embodiment of the neuromuscular electrode 1 is shown in FIG. 2A.
  • FIG. 2A shows the top surface of the neuromuscular electrode 1 and its proper location on the user's wrist.
  • the top surface of the neuromuscular electrode 1 contains printed instructions 46 and/or other visual indications 45 to help the user properly position it.
  • FIG. 2B shows the bottom surface of the neuromuscular electrode 1. The illustrative configuration allows muscle activity in the Thenar muscle group 51 to be evoked and sensed when the neuromuscular electrode 1 is positioned immediately proximal to the wrist crease 9, as shown in FIG. 2A.
  • Two bioelectrical transduction sites, 30 and 31, hereafter referred to as the stimulation sites, are positioned approximately midway between the lateral end 19 and medial end 17 of the neuromuscular electrode 1.
  • the two stimulation sites, 30 and 31, are arranged in a distal to proximal line such that one of the sites is near the distal end 18 of the neuromuscular electrode 1 and one of the sites is near the proximal end 20 of the neuromuscular electrode 1.
  • the stimulation sites may consist of stimulation electrodes comprised of delineated areas of bioelectrical signal transduction means that convert electronic signals into electrochemical ones and vice versa.
  • these sites are composed of a plurality of layers of different materials with substantially the same area.
  • a first layer is directly attached to the bottom face of the neuromuscular electrode 1 and is preferably formed by a thin layer of silver.
  • a second layer is attached to first layer and preferably consists of a silver-chloride salt.
  • a third layer is attached to second layer and contacts the user's skin on its exposed surface.
  • the third layer is preferably composed of an electrolyte hydrogel, such as, for example, sodium chloride.
  • the two stimulation sites, 30 and 31, will overlie the Median nerve 50.
  • the nerve 50 is stimulated by passing a low amplitude current (e.g ., typically less than 10 milliamps) through the two stimulation sites, 30 and 31.
  • the current is provided by an external source electrically coupled to contacts, 34 and 35, on the external connector 6.
  • the contacts, 34 and 35, and the stimulation sites, 30 and 31, are coupled by electrically conductive and insulated means, 32 and 33.
  • the detection sites are positioned at the extreme lateral end 19 and medial end 17 of the neuromuscular electrode 1 near its distal end 18.
  • the detection sites, 21 and 22 consist of detection electrodes comprised of delineated areas of bioelectrical signal transduction means that convert electronic signals into electrochemical ones and vice versa.
  • these sites are constructed in a substantially similar manner to the stimulation sites, 30 and 31.
  • Thenar muscles 51 will generate a myoelectric potential and create a bioelectrical potential difference between the lateral 21 and medial 22 detection sites due to the relative proximity of the lateral detection site 21 to the Thenar muscles 51.
  • This potential difference may be measured as a small (e.g ., typically less than 0.5 mV) differential voltage between contacts, 25 and 26, on the external connector 6.
  • the contacts, 25 and 26, and the detection sites, 21 and 22, are coupled by electrically conductive and insulated means, 23 and 24.
  • the measurement of the differential voltage signal is enhanced by the availability of a reference potential, which is provided by transduction site 27, hereafter referred to as the reference site, or reference electrode.
  • This site is positioned along the medial end 17 of the neuromuscular electrode 1 towards its proximal end 20.
  • the position of the reference site 27 is, however, not critical and has relatively little effect on the function of the invention.
  • the reference site 27 is constructed in a substantially similar manner to the stimulation sites, 30 and 31, and detection sites, 21 and 22.
  • the reference potential is made available at a contact 29 on the external connector 6, which is coupled to the reference site 27 by electrically conductive and insulated means 28.
  • the neuromuscular electrode 1 contains a temperature sensor 36, such as, for example, a DS 1820 (Dallas Semiconductor, Dallas, TX) or a thermistor.
  • the temperature sensitive part of the sensor 36 contacts the users skin directly or indirectly through an intermediary material that efficiently conducts heat.
  • the temperature sensor 36 can be placed at any available location within the area of the neuromuscular electrode 1.
  • the temperature sensor 36 is powered and transmits temperature information to electronic monitor 2 through two or more contacts, 39 and 40, on the external connector 6.
  • the contacts, 39 and 40, and the temperature sensor 36 are coupled by electrically conductive and insulated means, 37 and 38.
  • transduction sites and sensors have been contemplated and should be considered within the scope of the present invention.
  • One such configuration utilizes a single pair of transduction sites for both stimulation and detection through electronic multiplexing.
  • the electronic monitor 2 has a number of functions.
  • the monitor 2 detects, amplifies, processes and stores bioelectrical potentials, such as those generated by nerve or muscle activity. It also generates stimuli, such as steps of electrical current, with sufficient magnitude to trigger impulses in nerves or muscles. In addition, it communicates with the user and with external instruments, such as, for example, a personal computer.
  • the electronic monitor 2 includes a controller to process data and control the intensity and duration of stimulus applications.
  • FIG. 3 An illustrative block diagram of the electronic monitor 2 of FIG. 1 is shown in FIG. 3.
  • Differential amplifier 60 amplifies the voltage difference between the input terminals and generates a voltage that is proportional to that voltage difference.
  • the differential amplifier 60 of FIG. 3 is electrically coupled to detection sites, 21 and 22, and reference site 27. Since the bioelectrical signals from the body surface typically have a source impedance between about 5 K ⁇ to about 50 K ⁇ and contain large common mode signals, the differential amplifier 60 must have a high input impedance, a good common mode rejection ratio and a low leakage current. These requirements are preferably met by an instrumentation amplifier, such as, for example, the INA111 (Burr-Brown, Tuscon, AZ) or the AD621 (Analog Devices, Norwood, MA).
  • an instrumentation amplifier such as, for example, the INA111 (Burr-Brown, Tuscon, AZ) or the AD621 (Analog Devices, Norwood, MA
  • the differential amplifier 60 is electrically coupled to a signal conditioning unit 61 that prepares the signal for analog-to-digital conversion and subsequent processing.
  • the signal conditioning unit 61 preferably removes DC offsets, amplifies, low-pass filters, and creates a DC bias.
  • the signal conditioning unit 61 is electrically coupled to an analog-to-digital converter on the controller 63.
  • Temperature sensor interface electronics 62 power the temperature sensor and convert temperature related signals into a form interpretable by controller 63.
  • Stimulator 64 generates an electrical impulse with either or both of the magnitude and duration of the impulse being determined by signals from controller 63.
  • the stimulator 64 is preferably embodied by a circuit which gates the discharge of a capacitor charged to a high voltage (e.g ., 100 volts).
  • the capacitance value e.g ., 1 ⁇ F is chosen so that the discharge time constant (e.g ., several seconds) is much longer than the typical impulse duration ( e.g ., less than 1 millisecond).
  • the voltage across the capacitor is established by internal charging means, such as, for example, a DC-DC converter. In another embodiment, it is established by external charging means. In the later case, the stimulator 64 is capable of generating a finite number of electrical impulses before it has to be recharged by the external charging means.
  • Actuating means 65 are electrically coupled to processor 63 and preferably embodied by one or more push button switches.
  • Indicator 66 is also electrically coupled to controller 63 and preferably embodied in a single, or multi-segment, LED.
  • external interface 67 is electrically coupled to controller 63 and preferably embodied as a standard RS-232 serial interface.
  • the controller 63 performs analog-to-digital conversion, senses and controls I/O lines, and processes, analyzes and stores acquired data.
  • the controller 63 is preferably embodied as a single, integrated, low-cost embedded microcontroller. However, in other embodiments, the controller 63 is configured with multiple components, such as, for example, a microprocessor and external components that perform analog-to-digital conversion and other necessary functions.
  • FIG. 4 shows a schematic diagram of the circuitry of one embodiment of the electronic monitor 2 of FIG. 1.
  • the illustrative circuit of FIG. 4 includes a detection sub-circuit, a stimulation sub-circuit and a control and processing sub-circuit.
  • the detection stage is based on amplifier U1 , a type INA111 (Burr-Brown, Arlington, AZ) instrumentation amplifier.
  • Each of a pair of inputs of amplifier U1 , 100 and 101 is electrically coupled to one of the detector sites, 21 and 22, of FIG. 2B.
  • amplifier U1 has a reference pin 102 at which it receives a reference potential through electrical coupling to reference site 27 of FIG. 2B.
  • U1 is a monolithic instrumentation amplifier and requires one external component, a resistor, R7 , to establish its amplification gain, which is preferably a factor of 10.
  • Amplifier U1 is powered by a two sided symmetrical power supply providing + Vc 110 and - Vc 111 ( e.g ., 6 volts), as well as a ground 112.
  • + Vc 110, -Vc 111, and the ground 112 are provided by two batteries, B1 and B2, connected in series, as shown in FIG. 4.
  • the output of amplifier U1 is coupled through a high pass filter formed by capacitor C1 and resistor R1 to the input of a non-inverting amplifier formed by operational amplifier U2a .
  • the high pass filter removes any DC offset in the output of amplifier U1.
  • capacitor C1 and resistor R1 are chosen for a high pass corner frequency of about 2 Hz.
  • the gain of the non-inverting amplifier is established by resistors R2 and R10 and is preferably set to a gain of 500.
  • the output of first operational amplifier U2a is coupled to input of second operational amplifier U2b by a low pass filter formed by resistor R3 and capacitor C2 .
  • the low pass filter removes high frequency noise from the signal.
  • resistor R3 and capacitor C2 are chosen for a low pass corner frequency of about 3 KHz.
  • the second operational amplifier U2b is configured simply as an impedance buffer.
  • the output of amplifier U2b is coupled to an analog-to-digital conversion pin on microcontroller U4 by a DC biasing circuit consisting of capacitor C4 , along with resistors R8 and R9 .
  • the purpose of the DC biasing circuit is to insure that all signals vary from ground 112 to + Vc 110, since the analog-to-digital conversion electronics of microcontroller U4 operate only on positive voltages.
  • the detection stage also has a combination communication and power line 116, for interfacing to a "one-wire" temperature sensor 36 of FIG. 2B, connected to an I/O pin on microcontroller U4.
  • the stimulation sub-circuit of the apparatus is based on energy storage capacitor C3 , which is a high capacitance (e.g ., 1 ⁇ F or greater) and high voltage (e.g ., greater than 100 volts) capacitor.
  • capacitor C3 is charged to greater than 100 volts by an external charging means 105.
  • Capacitor C3 charging is accomplished by charging means 105, which passes electrical current between terminals 107 and 106, which are temporarily electrically coupled to capacitor C3 terminals 109 and 108 during the charging period. Once capacitor C3 is charged, charging means 105 is removed.
  • Electrical stimulation of nerve and muscle is accomplished by discharging capacitor C3 through leads 103 and 104, which are electrically coupled to stimulation sites, 30 and 31. Control of stimulation duration is provided by a power MOSFET transistor Q1, which gates discharge according to a digital signal from microcontroller U4. Resistor R4 protects transistor Q1 by limiting the current that flows through it.
  • microcontroller U4 which is preferably a type PIC12C71 (MicroChip, Chandler, AZ) microcontroller.
  • U4 provides processing and storage capabilities, analog-to-digital conversion and input/output control.
  • microcontroller U4 detects depression of switch S1, which is connected to an I/O pin and controls light emitting diode LED1, which is also connected to an I/O pin.
  • Resistor R6 limits current into the I/O pin when switch S1 is depressed and resistor R5 limits current through the light-emitting diode LED1.
  • serial communication 115 to external devices is provided by the remaining available I/O pin.
  • Control and processing algorithms are stored in microcontroller U4 and executed automatically upon application of power.
  • Other electronic circuitry may be used to perform the processes described above and is considered to be within the scope of the invention.
  • One skilled in the art knows how to design electronic circuitry to perform the functions outlined above.
  • a major object of the present invention is to serve as a detection system for CTS.
  • Conventional detection of CTS is based on an analysis of certain features of the evoked muscle response, typically the distal motor latency (DML).
  • the DML represents the time lag between stimulation of the Median nerve 50 immediately proximal to the wrist crease 9 and arrival of the neurally conducted impulse at the Thenar muscle group 51 after traversing the Carpal Tunnel.
  • One of the most common and consistent indications of CTS is an increase in the DML.
  • the vertical scale 121 indicates the amplitude of the muscle response in millivolts as measured between detection sites 21 and 22.
  • the large signal transients 123 that occur in the first 2 milliseconds represent stimulus associated artifacts and are unrelated to activity in the Thenar muscles 51.
  • An evoked muscle response 120 may be characterized by many parameters including, but not limited to, a time to onset 124, a time to peak 125, a peak amplitude 126, a peak to peak amplitude 127 and a peak to peak width 128.
  • the time to onset 124 is about 3.7 milliseconds
  • the time to peak 125 is about 5.8 milliseconds.
  • the intervening tissue acts as a low pass filter. This results in amplitude attenuation and temporal spreading of the detected waveform as compared to measurements taken directly over the Thenar muscles 51. The decrease in amplitude results in a reduction in the signal-to-noise ratio of the detected muscle response 120. The temporal spreading obscures sharp characteristic features of the response 120.
  • analysis of the muscle response 120 is significantly enhanced by preprocessing it prior to determination of its characteristic features.
  • One such preprocessing step is to take the second derivative of the muscle response 120 as shown in FIG. 6.
  • the advantageous nature of this preprocessing step is evident from the fact that the second derivative 130 (solid line) has a peak 131 near the onset 124 of the muscle response 120. Consequently, it is possible to accurately and consistently obtain a latency estimate 133 by simply detecting the presence of this peak 131.
  • a direct estimation of the time to onset 124 from the muscle response 120 requires establishment of an arbitrary voltage threshold which may vary significantly among different individuals.
  • the sharp peak 131 in the second derivative 130 of FIG. 6 is obtained by first smoothing the muscle response 120, such as by, for example, convolving it with a normalized Gaussian waveform with a predetermined standard deviation. Subsequently, the first derivative is calculated by estimating the instantaneous slope for each data point in the muscle response 120. The second derivative is then calculated by estimating the instantaneous slope for each data point in the just computed first derivative. In order to conserve dynamic memory resources, the first and second derivatives 130 can be sequentially calculated for small sections of the muscle response 120 and the values discarded if they do not indicate the presence of a peak 131 in the second derivative 130.
  • the largest positive peak within a defined time window 136 is selected.
  • This time window 136 is defined as occurring between two time limits, 134 and 135.
  • the lower time limit 134 is predetermined and reflects the amount of time required for artifacts 123 associated with the stimulus to decay to an amplitude that is significantly less than the amplitude of the actual signal evoked from the muscle 120.
  • the lower time limit 134 is preferably about 2.5 milliseconds. Other lower time limits may, however, be used.
  • the upper time limit 135 is determined dynamically.
  • the upper time limit 135 is set to reflect the time during which the first derivative of the evoked muscle response 120 is positive. In other words, it reflects the period of time during which the evoked muscle response 120 is increasing. By establishing the upper time limit 135 in this fashion, large peaks 132 in the second derivative of the response 130, which occur in the latter portion of the response, are ignored and, therefore, do not result in incorrect estimates of the latency 133.
  • FIG. 7 shows an illustrative algorithm for detecting CTS using an apparatus of the invention in an entirely automated fashion.
  • the algorithm commences in process step 140 by activation of actuating means 65, such as, for example, by depression of a START switch S1. If the actuation means have been activated, the algorithm continues with process step 142. Otherwise process step 140 is continuously executed until the actuating means are activated.
  • the root-mean-square (RMS) value of the noise is obtained in the absence of any electrical stimulation and compared against a predetermined threshold, n max . If the noise RMS is less than n max , the algorithm continues with process step 146.
  • actuating means 65 such as, for example, by depression of a START switch S1.
  • the algorithm proceeds to process step 144, in which indicator 66 is used to indicate a problem with the noise level to the user. Subsequently, the algorithm returns to process step 140 and waits for reactivation of the START switch S1.
  • the magnitude of stimuli to be used in diagnosing CTS is determined.
  • this parameter is determined automatically without user involvement. This is accomplished by gradually increasing the stimulation duration in predetermined increments (e.g ., 25 microseconds) until the evoked muscle response 120 meets one or more predetermined criteria.
  • the stimulation duration is increased until the peak of the first derivative of the evoked muscle response 120 exceeds a predetermined threshold (e.g ., 0.1 mV/ms). If the proper stimulation duration is obtained, the algorithm proceeds from process step 148 to process step 152.
  • the algorithm proceeds to process step 150, in which indicator 66 is used to indicate a problem with the determination of stimulation magnitude to the user. Subsequently, the algorithm returns to process step 140 and waits for reactivation of the START switch.
  • the algorithm Upon determination of the proper stimulation magnitude, the algorithm proceeds with process step 152.
  • the Median nerve 50 is stimulated at a predetermined rate (e.g ., 2 Hz) for a predetermined duration ( e . g ., 2 seconds).
  • a predetermined rate e.g ., 2 Hz
  • a predetermined duration e.g ., 2 seconds
  • DML distal motor latency
  • the plurality of DML estimates are combined to obtain a mean DML ( m ) and a standard deviation ( s ) about this mean.
  • the algorithm then proceeds to process step 153 in which m and s are adjusted for variations in skin temperature.
  • m corrected m uncorrected + K 1 ⁇ T + k 2
  • S corrected S uncorrected + K 1 ⁇ T + k 2
  • the corrected mean DML ( m corrected ) and standard deviation ( s corrected ) represent the expected values at room temperature ( i.e ., 25° C or 298° K).
  • the skin temperature, as measured by the temperature sensor 36, is represented by the variable T .
  • the values of constants k 1 and k 2 are determined by a temperature calibration process. In this process, multiple measurements of the mean DML are obtained at a variety of temperatures spanning the expected range of temperatures over which the invention is normally used ( e . g ., 25°C to 40° C). Subsequently, a linear regression is performed between the temperatures and the mean DML measurements.
  • the constants k 1 and k 2 are determined directly from the regression coefficients.
  • process step 154 in which the standard deviation of the DML measurements, s , is compared against a predetermined threshold, s min. If s is larger or equal to s min, process step 156 is executed. Process step 156 evaluates the number of times m and s have been determined. If these values have been calculated only once, the algorithm returns to process step 146, where determination of the proper stimulation level and all subsequent processing is repeated. If m and s have been determined twice, however, process step 158 is executed, resulting in indication of a diagnostic error to the user through indicator 66. Subsequently, the algorithm returns to process step 140 and waits for reactivation of the START switch S1.
  • process step 160 the mean of the DML estimates, m , is compared against a first predetermined latency threshold, t normal . If m is less than t normal , the algorithm proceeds to process step 162, in which a normal (i.e., user does not have CTS) test result is indicated to user through indicator 66. Subsequently, the algorithm returns to process step 140 and waits for reactivation of the START switch S1.
  • a normal i.e., user does not have CTS
  • the algorithm proceeds with process step 164, in which the mean distal motor latency, m , is compared against a second predetermined latency value, t CTS. If m is greater than t CTS, the algorithm proceeds to process step 166, in which an abnormal (i.e ., user has CTS) test result is indicated to user through indicator 66. Subsequently, the algorithm returns to process step 140 and waits for reactivation of the START switch S1.
  • the algorithm continues with process step 168.
  • the Median nerve 150 is stimulated by pairs of electrical stimuli spaced apart at a predetermined temporal interval (e.g ., 3 milliseconds).
  • a predetermined temporal interval e.g . 3 milliseconds.
  • the difference between the DML estimated from the first and second stimuli is determined.
  • the plurality of DML difference estimates are combined to obtain a mean DML difference ( m' ) and a standard deviation ( s' ) about this mean.
  • the algorithm proceeds to process step 170 in which the mean DML difference, m' is compared against a predetermined threshold, t shift .
  • process step 166 is executed, in which an abnormal test result is indicated to the user, as described above. If this inequality does not hold, then an unknown test result is indicated to user in process step 172. Subsequently, the algorithm returns to process step 140 and waits for activation of the START switch S1 .
  • parameters other than the DML may be incorporated into the diagnostic algorithm.
  • Illustrative parameters include: waveform features of the evoked muscle response 120, such as, for example, the amplitude and width.
  • Additional illustrative parameters include waveform features of processed forms of the evoked muscle response 120, such as, for example, its derivatives, its Fourier transform, and other parameters derived from statistical analyses ( e.g ., principal component analysis).
  • additional parameters are obtained by comparison of any of the above parameters at different stimulation levels.
  • the apparatus of the present invention may be used to detect other forms of nerve disease and to evaluate neuromuscular blockade.
  • the train-of-four (TOF) protocol which is commonly used to evaluate the degree of neuromuscular blockade in anesthetized patients, is readily implemented using an apparatus of the invention.
  • a predetermined number usually four
  • a predetermined rate e . g ., 2 Hz
  • the ratio of the amplitude of the last of the plurality of muscle responses to be evoked is divided by the amplitude of the first of the plurality of muscle responses to be evoked. This ratio is recognized as a sensitive indicator of neuromuscular blockade.
  • the disclosed invention provides a new approach to monitoring neuromuscular physiology. Apparatus and methods are described for the substantially automated and highly efficient measurement of many different parameters of neuromuscular physiology. These indicators may be used to detect Carpal Tunnel Syndrome (CTS) and other peripheral nerve diseases, as well as to monitor neuromuscular blockade caused by pathological, pharmacological and chemical means.
  • CTS Carpal Tunnel Syndrome
  • the invention possesses the significant advantage that, unlike conventional measurements of nerve conduction across the wrist, the disclosed invention provides for a single integrated neuromuscular electrode that is placed immediately proximal to the wrist ( i.e ., the wrist crease). This is a very familiar anatomic location and so the placement operation is rapidly and easily undertaken by most adults.
  • the disclosed invention does not require placement of multiple sets of electrodes on both sides of the wrist, which is a difficult and error prone procedure for non-experts.
  • An additional advantage of the disclosed invention emerges from the fact that the integrated neuromuscular electrodes may be manufactured as a low-cost, disposable item. Consequently, the possibility of cross-contamination among users of the apparatus is significantly reduced. Furthermore, the low-cost, and ease of use will promote frequent monitoring of neuromuscular disorders, such as CTS, providing the potential benefits of early detection and regular tracking of the disease.
  • Another advantage of the present invention is that the process of evoking, detecting and processing neuromuscular signals is carried out in an entirely automated fashion, without requiring involvement of either the user of the apparatus or trained personnel.
  • a further advantage of the present invention is that the smallest and fewest electrical stimuli consistent with an accurate diagnostic assessment are used. As a result, discomfort to the user is minimized and, in most cases, eliminated entirely.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Electrophonic Musical Instruments (AREA)

Claims (8)

  1. Eine Apparatur zum Bestimmen einer physiologischen Funktion in einem Arm und einer Hand eines Individuums, aufweisend:
    einen Stimulator (30) zum Erzeugen und Anwenden eines Stimulus, einen Detektor (22) zur Detektion eines myoelektrischen Potentials und einen Kontroller (2), wobei:
    die Apparatur so konfiguriert ist, dass sie lösbar an dem Arm des Individuums, im Wesentlichen in der Nähe des Handgelenks des Individuums, befestigt werden kann und der Stimulator (30) und der Detektor (22) auf der Apparatur angebracht werden, so dass, wenn die Apparatur am Unterarm (8) des Individuums im Wesentlichen in der Nähe des Handgelenks des Individuums befestigt wird, der Stimulator (30) in der Nähe des genannten Handgelenks angeordnet wird, wobei Anwendung des genannten Stimulus einen Nerv (50) stimuliert, der das genannte Handgelenk überquert, und der Detektor (22) in der Nähe des genannten Handgelenkes angeordnet ist, wobei das genannte myoelektrische Potential durch einen Muskel (5), der mit dem genannten Nerv in der genannten Hand des genannten Individuums in Verbindung steht, als Antwort auf den genannten Stimulus erzeugt wird und
    der Kontroller (2) so angeordnet ist, um eine physiologische Funktion als Antwort auf den genannten Stimulus und das genannte myoelektrische Potential auszuwerten.
  2. Apparatur aus Anspruch 1, wobei der genannte Kontroller (2) weiterhin so angeordnet ist, um eine Verzögerung zwischen Anwendung des genannten Stimulus und Detektion des genannten myoelektrischen Potentials zu bestimmen und wahlweise
    der genannte Kontroller (2) weiterhin so angeordnet ist, dass die genannte Verzögerung mit der Gegenwart oder Abwesenheit eines Karpaltunnelsyndroms korreliert.
  3. Die Apparatur aus Anspruch 1, wobei der genannte Stimulus ein elektrischer Stimulus oder ein magnetischer Stimulus ist.
  4. Die Apparatur aus Anspruch 1, weiterhin aufweisend eines aus:
    a) einer Stimulationselektrode in elektrischer Verbindung mit dem genannten Stimulator (30),
    b) einer Detektionselektrode in elektrischer Verbindung mit dem genannten Detektor (22),
    c) einer Referenzelektrode (27), positioniert, um auf dem genannten Arm in der Nähe des genannten Handgelenks und in elektrischer Verbindung mit dem genannten Kontroller platziert zu werden,
    d) einem Temperaturfühler (36) in elektrischer Verbindung mit dem genannten Kontroller,
    e) einem Indikator in elektrischer Verbindung mit dem genannten Kontroller und so angeordnet, um Hinweise von dem genannten Kontroller (2) zu empfangen und die genannte physiologische Funktion anzuzeigen, in welchem Falle wahlweise entweder:
    i) der genannte Indikator weiterhin so angeordnet wird, dass er die Gegenwart oder Abwesenheit von Karpaltunnelsyndrom anzeigt, oder
    ii) der genannte Indikator eine Leuchtdiode aufweist und
    f) einem Kommunikationsanchluss, so angeordnet, um die Kommunikation zwischen der genannten Apparatur und einer externen Vorrichtung zu ermöglichen.
  5. Die Apparatur aus Anspruch 1, wobei
    der Stimulator eine Stimulationselektrode (30) beinhaltet,
    der Detektor eine Detektionselektrode (22) beinhaltet,
    und wobei die genannten Elektroden (30, 22) so abgemessen und geformt sind, um sie auf einer vorderen Seite des genannten Arms (8) des genannten Individuums zu positionieren und eine Elektrodenkonfiguration aufweisen, um neuromuskuläre Funktionen in einem Arm des genannten Individuums zu bestimmen.
  6. Apparatur aus Anspruch 5 und eines aus:
    a) der Elektrodenkonfiguration, weiterhin aufweisend einen Temperatursensor (36),
    b) der Elektrodenkonfiguration, weiterhin aufweisend eine Referenzelektrode (27),
    c) der genannten Stimulationselektrode (30) und der genannten Detektionselektrode (22), die in einem Elektrodengehäuse enthalten sind, in welchem Fall wahlweise eines aus:
    i) dem genannten Elektrodengehäuse so angepasst ist, dass es auf dem genannten Arm (8) des genannten Individuums im Wesentlichen in der Nähe des genannten Handgelenks platziert werden kann, in welchem Falle weiterhin wahlweise,
    weiterhin eine zweite Stimulationselektrode (31) enthalten ist, in welchem Falle weiterhin wahlweise entweder:
    α) die genannte Stimulationselektrode (30) und die genannte zweite Stimulationselektrode (31) im Wesentlichen im Zentrum des genannten Elektrodengehäuses positioniert sind, oder
    β) die genannte Stimulationselektrode (30) und die genannte zweite Stimulationselektrode (30) und die genannte zweite Stimulationselektrode (31) so angeordnet sind, dass eine der genannten Stimulationselektroden an einem Ende des genannten Etektrodengehäuses positioniert ist und die andere der genannten Stimulationselektroden an dem gegenüberliegenden Ende des genannten Elektrodengehäuses positioniert ist, so dass wenn das genannte Elektrodengehäuse auf die genannte vordere Seite des genannten Arms platziert wird, eine der genannten Stimulationselektroden sich sofort in der Nähe des genannten Handgelenks befindet und die andere der genannten Stimulationselektroden sich an einer Position weiter rumpfwärts von dem genannten Handgelenk befindet,
    ii) die Elektrodenkonfiguration weiterhin eine zweite Detektionselektrode (26) aufweist und wahlweise die genannte Detektionselektrode (25) und die genannte zweite Detektionselektrode (26) so angeordnet sind, dass eine der genannten Detektionselektroden an einem Ende des genannten Elektrodengehäuses positioniert ist und die andere der genannten Detektionselektroden an dem gegenüberliegenden Ende des genannten Elektrodengehäuses positioniert ist, so dass, wenn das genannte Elektrodengehäuse an der genannten vorderen Seite des genannten Arms platziert wird, eine der genannten Detektionselektroden sich in der Nähe der medialen Seite des genannten Arms befindet und die andere der genannten Detektionselektroden sich in der Nähe der lateralen Seite des genannten Arms befindet,
    iii) die Elektrodenkonfiguration weiterhin einen Befestigungsmechanismus aufweist, um das genannte Elektrodengehäuse an dem genannten Arm des genannten Individuums zu befestigen und
    iv) das genannte Elektrodengehäuse einen Anschluss aufweist, der für elektrische Übertragung mit einer Apparatur gemäß Anspruch 1 geeignet ist, oder das genannte Elektrodengehäuse wegwerfbar ist.
  7. Ein Verfahren zum Bestimmen von Nervenleitungsparametern in einem Arm eines Individuums, aufweisend die Schritte aus:
    a) Anwenden eines Stimulus in der Nähe eines Handgelenks des genannten Individuums, wobei das Anwenden des genannten Stimulus einen Nerv stimuliert, der das genannte Handgelenk überquert,
    b) Detektieren eines myoelektrischen Potentials in der Nähe des Handgelenks des Individuums, wobei das myoelektrische Potential von einem Muskel in der Hand des genannten Individuums als Antwort auf den genannten Stimulus erzeugt wird, wobei der genannte Muskel mit dem genannten Nerv kommuniziert,
    c) Verarbeiten des genannten Stimulus und des genannten myoelektrischen Potentials, um Verarbeitungsergebnisse zu erhalten und
    d) Auswerten der genannten Nervenleitungsparameter, basierend auf den genannten Verarbeitungsergebnissen.
  8. Das Verfahren aus Anspruch 7 und einem aus:
    a) dem Verfahren, weiterhin aufweisend den Schritt des Anzeigens der Ergebnisse des genannten Auswertungsschrittes, in welchem Falle wahlweise der genannte Anzeigeschritt weiterhin den Schritt aufweist, dass die Unterschiede zwischen den genannten Nervenleitungsparametern und einem erwarteten Wert angezeigt werden,
    b) dem genannten Verarbeitungsschritt, weiterhin aufweisend den Schritt der Bestimmung einer Verzögerung zwischen Anwendung des genannten Stimulus und der Detektion des genannten myoelektronischen Potentials, in welchem Falle wahlweise der genannte Schritt der Bestimmung einer Verzögerung zwischen dem Anwenden des genannten Stimulus und der Detektion des genannten myoelektrischen Potentials einen Schritt der Bestimmungen einer zweiten Ableitung des genannten myoelektrischen Potentials aufweist,
    c) dem Verfahren, weiterhin aufweisend den Schritt des Bestimmens einer ersten Ableitung des genannten myoelektrischen Potentials, in diesem Falle wahlweise weiterhin aufweisend den Schritt der Wiederholung der Schritte a) und b) aus Anspruch 7 mit inkrementell ansteigenden Stimulusdauern, bis die genannte erste Ableitung für eines der genannten myoelektrischen Potentiale einen vorher bestimmten Wert überschreitet,
    d) dem genannten Bewertungsschritt, weiterhin aufweisend den Schritt des Vergleichs des genannten Nervenleitungsparameters mit einem erwarteten Wert und
    e) weiterhin aufweisend den Schritt der Bestimmung einer VerztSgerung zwischen Anwendung des genannten Stimulus und Detektion des genannten myoelektrischen Potentials für zumindest zwei Stimulusanwendungen und Vergleich der Verzögerungen, die in Antwort auf die Anwendungen für jede der genannten zumindest zwei Stimulusanwendungen bestimmt werden.
EP98931451A 1997-07-01 1998-06-22 Gerät und verfahren zur beurteilung von neuromuskulärer funktion Expired - Lifetime EP0993270B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/886,861 US5851191A (en) 1997-07-01 1997-07-01 Apparatus and methods for assessment of neuromuscular function
US886861 1997-07-01
PCT/US1998/012922 WO1999001064A1 (en) 1997-07-01 1998-06-22 Apparatus and methods for assessment of neuromuscular function

Publications (2)

Publication Number Publication Date
EP0993270A1 EP0993270A1 (de) 2000-04-19
EP0993270B1 true EP0993270B1 (de) 2007-10-10

Family

ID=25389937

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98931451A Expired - Lifetime EP0993270B1 (de) 1997-07-01 1998-06-22 Gerät und verfahren zur beurteilung von neuromuskulärer funktion

Country Status (8)

Country Link
US (3) US5851191A (de)
EP (1) EP0993270B1 (de)
JP (2) JP3657277B2 (de)
AT (1) ATE375116T1 (de)
AU (1) AU750315B2 (de)
CA (1) CA2295132C (de)
DE (1) DE69838549D1 (de)
WO (1) WO1999001064A1 (de)

Families Citing this family (160)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7628761B2 (en) * 1997-07-01 2009-12-08 Neurometrix, Inc. Apparatus and method for performing nerve conduction studies with localization of evoked responses
US6132386A (en) * 1997-07-01 2000-10-17 Neurometrix, Inc. Methods for the assessment of neuromuscular function by F-wave latency
US6564078B1 (en) 1998-12-23 2003-05-13 Nuvasive, Inc. Nerve surveillance cannula systems
ATE306213T1 (de) * 1998-12-23 2005-10-15 Nuvasive Inc Vorrichtungen zur kannulation und zur nervenüberwachung
EP1253854A4 (de) 1999-03-07 2010-01-06 Discure Ltd Verfahren und vorrichtung für computerisierte chirurgie
AU4681799A (en) * 1999-06-14 2001-01-02 John M. Agee Method and apparatus for monitoring tendon motion
EP1095670B1 (de) * 1999-10-29 2008-05-07 Compex Medical S.A Neuromuskuläres Stimulationsgerät mit Aufnahme der Muskelreaktion auf den elektrischen Stimulationsimpuls
JP4854900B2 (ja) * 1999-11-24 2012-01-18 ヌバシブ， インコーポレイテッド 筋電計測法
US6466817B1 (en) 1999-11-24 2002-10-15 Nuvasive, Inc. Nerve proximity and status detection system and method
US20020055688A1 (en) * 2000-05-18 2002-05-09 Jefferson Jacob Katims Nervous tissue stimulation device and method
WO2001087154A1 (en) 2000-05-18 2001-11-22 Nuvasive, Inc. Tissue discrimination and applications in medical procedures
AU6976801A (en) 2000-06-08 2001-12-17 Nuvasive Inc Relative nerve movement and status detection system and method
US6564079B1 (en) 2000-07-27 2003-05-13 Ckm Diagnostics, Inc. Electrode array and skin attachment system for noninvasive nerve location and imaging device
US20030105503A1 (en) * 2001-06-08 2003-06-05 Nuvasive, Inc. Relative nerve movement and status detection system and method
JP4295086B2 (ja) 2001-07-11 2009-07-15 ヌバシブ， インコーポレイテッド 手術の間の神経近接度、神経の方向、および病理学を決定するシステムおよび方法
EP1435828A4 (de) 2001-09-25 2009-11-11 Nuvasive Inc System und verfahren zur durchführung von chirurgischen eingriffen und untersuchungen
US7664544B2 (en) 2002-10-30 2010-02-16 Nuvasive, Inc. System and methods for performing percutaneous pedicle integrity assessments
US6829510B2 (en) * 2001-12-18 2004-12-07 Ness Neuromuscular Electrical Stimulation Systems Ltd. Surface neuroprosthetic device having an internal cushion interface system
US8147421B2 (en) 2003-01-15 2012-04-03 Nuvasive, Inc. System and methods for determining nerve direction to a surgical instrument
US7582058B1 (en) 2002-06-26 2009-09-01 Nuvasive, Inc. Surgical access system and related methods
US8137284B2 (en) 2002-10-08 2012-03-20 Nuvasive, Inc. Surgical access system and related methods
US7691057B2 (en) 2003-01-16 2010-04-06 Nuvasive, Inc. Surgical access system and related methods
US9462960B2 (en) * 2003-02-21 2016-10-11 3Dt Holdings, Llc Impedance devices and methods of using the same to obtain luminal organ measurements
US7819801B2 (en) 2003-02-27 2010-10-26 Nuvasive, Inc. Surgical access system and related methods
US20040225228A1 (en) 2003-05-08 2004-11-11 Ferree Bret A. Neurophysiological apparatus and procedures
AU2004263152B2 (en) 2003-08-05 2009-08-27 Nuvasive, Inc. Systems and methods for performing dynamic pedicle integrity assessments
US7179231B2 (en) * 2003-08-25 2007-02-20 Wisys Technology Foundation, Inc., Apparatus and method for analyzing nerve conduction
EP1680177B1 (de) 2003-09-25 2017-04-12 NuVasive, Inc. Chirurgisches zugangssystem
US7905840B2 (en) 2003-10-17 2011-03-15 Nuvasive, Inc. Surgical access system and related methods
US8313430B1 (en) 2006-01-11 2012-11-20 Nuvasive, Inc. Surgical access system and related methods
SE0302746D0 (sv) * 2003-10-17 2003-10-17 Uppsala Laekarkonsult Ab Multielectrode
US8326410B2 (en) * 2004-02-17 2012-12-04 Neurometrix, Inc. Method for automated analysis of submaximal F-waves
WO2006042241A2 (en) 2004-10-08 2006-04-20 Nuvasive, Inc. Surgical access system and related methods
US8613745B2 (en) 2004-10-15 2013-12-24 Baxano Surgical, Inc. Methods, systems and devices for carpal tunnel release
US7887538B2 (en) 2005-10-15 2011-02-15 Baxano, Inc. Methods and apparatus for tissue modification
US9247952B2 (en) 2004-10-15 2016-02-02 Amendia, Inc. Devices and methods for tissue access
US9101386B2 (en) 2004-10-15 2015-08-11 Amendia, Inc. Devices and methods for treating tissue
US7578819B2 (en) 2005-05-16 2009-08-25 Baxano, Inc. Spinal access and neural localization
US8062300B2 (en) 2006-05-04 2011-11-22 Baxano, Inc. Tissue removal with at least partially flexible devices
EP1799129B1 (de) 2004-10-15 2020-11-25 Baxano, Inc. Vorrichtungen zur gewebeentfernung
US8048080B2 (en) 2004-10-15 2011-11-01 Baxano, Inc. Flexible tissue rasp
US7553307B2 (en) 2004-10-15 2009-06-30 Baxano, Inc. Devices and methods for tissue modification
US20100331883A1 (en) 2004-10-15 2010-12-30 Schmitz Gregory P Access and tissue modification systems and methods
US8221397B2 (en) 2004-10-15 2012-07-17 Baxano, Inc. Devices and methods for tissue modification
US7738969B2 (en) 2004-10-15 2010-06-15 Baxano, Inc. Devices and methods for selective surgical removal of tissue
US20110190772A1 (en) 2004-10-15 2011-08-04 Vahid Saadat Powered tissue modification devices and methods
US7938830B2 (en) 2004-10-15 2011-05-10 Baxano, Inc. Powered tissue modification devices and methods
US7857813B2 (en) 2006-08-29 2010-12-28 Baxano, Inc. Tissue access guidewire system and method
US8257356B2 (en) 2004-10-15 2012-09-04 Baxano, Inc. Guidewire exchange systems to treat spinal stenosis
US8430881B2 (en) 2004-10-15 2013-04-30 Baxano, Inc. Mechanical tissue modification devices and methods
EP1656883A1 (de) * 2004-11-10 2006-05-17 Universite Libre De Bruxelles Tragbares Gerät zur Messung eines EMG-Signals
US20060173374A1 (en) * 2005-01-31 2006-08-03 Neubardt Seth L Electrically insulated surgical probing tool
US7785253B1 (en) 2005-01-31 2010-08-31 Nuvasive, Inc. Surgical access system and related methods
US7643884B2 (en) 2005-01-31 2010-01-05 Warsaw Orthopedic, Inc. Electrically insulated surgical needle assembly
EP2409641B1 (de) 2005-02-02 2017-07-05 NuVasive, Inc. Gerät zur neurophysiologischen Bewertung bei chirurgischen Operationen im Bereich der Wirbelsäule
US8568331B2 (en) 2005-02-02 2013-10-29 Nuvasive, Inc. System and methods for monitoring during anterior surgery
US7424322B2 (en) * 2005-02-03 2008-09-09 Cardinal Health 209, Inc. Method and apparatus for stimulus artifact suppression
US20060178594A1 (en) * 2005-02-07 2006-08-10 Neubardt Seth L Apparatus and method for locating defects in bone tissue
US8092455B2 (en) 2005-02-07 2012-01-10 Warsaw Orthopedic, Inc. Device and method for operating a tool relative to bone tissue and detecting neural elements
US20060200023A1 (en) * 2005-03-04 2006-09-07 Sdgi Holdings, Inc. Instruments and methods for nerve monitoring in spinal surgical procedures
US20070185409A1 (en) * 2005-04-20 2007-08-09 Jianping Wu Method and system for determining an operable stimulus intensity for nerve conduction testing
CA2544331A1 (en) * 2005-04-20 2006-10-20 Excel-Tech Ltd. Device, method and stimulus unit for testing neuromuscular function
US20070129771A1 (en) * 2005-04-20 2007-06-07 Kurtz Ronald L Device, method and stimulus unit for testing neuromuscular function
US7640057B2 (en) * 2005-04-25 2009-12-29 Cardiac Pacemakers, Inc. Methods of providing neural markers for sensed autonomic nervous system activity
WO2006119532A1 (en) * 2005-05-13 2006-11-16 Mcleay, Charmaine, A., M. Detection of muscular disorders
US8740783B2 (en) 2005-07-20 2014-06-03 Nuvasive, Inc. System and methods for performing neurophysiologic assessments with pressure monitoring
EP1912578B1 (de) 2005-07-28 2018-02-07 NuVasive, Inc. Totalbandscheibenersatzsystem
AU2006280946B2 (en) 2005-08-19 2013-05-02 Neuronetrix Solutions, Llc Controller for neuromuscular testing
WO2007038290A2 (en) 2005-09-22 2007-04-05 Nuvasive, Inc. Multi-channel stimulation threshold detection algorithm for use in neurophysiology monitoring
US8568317B1 (en) 2005-09-27 2013-10-29 Nuvasive, Inc. System and methods for nerve monitoring
US8062298B2 (en) 2005-10-15 2011-11-22 Baxano, Inc. Flexible tissue removal devices and methods
US8366712B2 (en) 2005-10-15 2013-02-05 Baxano, Inc. Multiple pathways for spinal nerve root decompression from a single access point
US8092456B2 (en) 2005-10-15 2012-01-10 Baxano, Inc. Multiple pathways for spinal nerve root decompression from a single access point
US9014798B2 (en) * 2005-10-20 2015-04-21 Neurometrix, Inc. Automated stimulus artifact removal for nerve conduction studies
US7632239B2 (en) * 2005-11-16 2009-12-15 Bioness Neuromodulation Ltd. Sensor device for gait enhancement
JP4738159B2 (ja) * 2005-12-12 2011-08-03 株式会社Ｉｈｉ 筋電位計測用電極装置
US20070149892A1 (en) * 2005-12-22 2007-06-28 Neurotron Medical Inc. Apparatus for neuromuscular function signal acquisition
US9339641B2 (en) * 2006-01-17 2016-05-17 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US20100168501A1 (en) * 2006-10-02 2010-07-01 Daniel Rogers Burnett Method and apparatus for magnetic induction therapy
US9610459B2 (en) * 2009-07-24 2017-04-04 Emkinetics, Inc. Cooling systems and methods for conductive coils
MX2008013895A (es) 2006-05-01 2009-01-29 Bioness Neuromodulation Ltd Sistemas de estimulacion electrica funcionales mejorados.
CA2556165A1 (en) * 2006-08-08 2008-02-08 Richard Kerber Method and apparatus for precluding plant trunks from freezing
US7917201B2 (en) * 2006-08-23 2011-03-29 Neurometrix, Inc. Method and apparatus for determining optimal neuromuscular detection sites, novel diagnostic biosensor array formed in accordance with the same, and novel method for testing a patient using the novel diagnostic biosensor array
US8506502B2 (en) * 2006-09-16 2013-08-13 Terence Gilhuly Sensors and sensing for monitoring neuromuscular blockade
US9005102B2 (en) 2006-10-02 2015-04-14 Emkinetics, Inc. Method and apparatus for electrical stimulation therapy
US10786669B2 (en) 2006-10-02 2020-09-29 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US11224742B2 (en) 2006-10-02 2022-01-18 Emkinetics, Inc. Methods and devices for performing electrical stimulation to treat various conditions
WO2008076372A2 (en) * 2006-12-15 2008-06-26 Neurometrix, Inc. Neurological diagnostic and therapeutic system utilizing function-specific modules
JP5005331B2 (ja) * 2006-12-19 2012-08-22 富士重工業株式会社 筋力センサ
US7987001B2 (en) 2007-01-25 2011-07-26 Warsaw Orthopedic, Inc. Surgical navigational and neuromonitoring instrument
US20080183074A1 (en) * 2007-01-25 2008-07-31 Warsaw Orthopedic, Inc. Method and apparatus for coordinated display of anatomical and neuromonitoring information
US8374673B2 (en) 2007-01-25 2013-02-12 Warsaw Orthopedic, Inc. Integrated surgical navigational and neuromonitoring system having automated surgical assistance and control
AU2008236665B2 (en) * 2007-04-03 2013-08-22 Nuvasive, Inc. Neurophysiologic monitoring system
US9042978B2 (en) * 2007-05-11 2015-05-26 Neurometrix, Inc. Method and apparatus for quantitative nerve localization
WO2009032363A1 (en) 2007-09-06 2009-03-12 Baxano, Inc. Method, system and apparatus for neural localization
US8192436B2 (en) 2007-12-07 2012-06-05 Baxano, Inc. Tissue modification devices
US9314253B2 (en) 2008-07-01 2016-04-19 Amendia, Inc. Tissue modification devices and methods
US8409206B2 (en) 2008-07-01 2013-04-02 Baxano, Inc. Tissue modification devices and methods
US8398641B2 (en) 2008-07-01 2013-03-19 Baxano, Inc. Tissue modification devices and methods
AU2009271047B2 (en) 2008-07-14 2014-04-17 Baxano Surgical, Inc. Tissue modification devices
US8271659B2 (en) * 2008-09-04 2012-09-18 Oracle International Corporation Methods and systems for automatic removal and replacement of connections in a pool rendered stale by a firewall
US9138161B2 (en) * 2008-11-18 2015-09-22 Qualcomm Incorporated Methods, apparatus and sensor for measurement of cardiovascular quantities
US9084551B2 (en) 2008-12-08 2015-07-21 Medtronic Xomed, Inc. Method and system for monitoring a nerve
CA2750917A1 (en) 2008-12-26 2010-07-01 Scott Spann Minimally-invasive retroperitoneal lateral approach for spinal surgery
US20100210965A1 (en) * 2009-02-13 2010-08-19 Gozani Shai N Apparatus and method for the detection of neuromuscular signals
WO2010105261A2 (en) 2009-03-13 2010-09-16 Baxano, Inc. Flexible neural localization devices and methods
US9351845B1 (en) 2009-04-16 2016-05-31 Nuvasive, Inc. Method and apparatus for performing spine surgery
US8287597B1 (en) 2009-04-16 2012-10-16 Nuvasive, Inc. Method and apparatus for performing spine surgery
WO2010136946A2 (en) * 2009-05-29 2010-12-02 Koninklijke Philips Electronics N.V. Capacitive sensing apparatus
US8394102B2 (en) 2009-06-25 2013-03-12 Baxano, Inc. Surgical tools for treatment of spinal stenosis
AU2010313487A1 (en) 2009-10-26 2012-05-24 Emkinetics, Inc. Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues
US20110230785A1 (en) * 2010-03-16 2011-09-22 ProNerve, LLC Somatosensory Evoked Potential (SSEP) Automated Alert System
US9775531B2 (en) * 2010-06-09 2017-10-03 Techmedic Development International B.V. Sensor device, processing device, and measurement system for acquiring a biopotential
KR101906884B1 (ko) 2010-09-16 2018-10-11 뉴로메트릭스 인코포레이티드 비복 신경 전도 속도 및 진폭의 자동 측정 장치 및 방법
US10004445B2 (en) 2010-09-16 2018-06-26 Neurometrix, Inc. Apparatus and method for stimulator on-skin short detection
US9392953B1 (en) 2010-09-17 2016-07-19 Nuvasive, Inc. Neurophysiologic monitoring
US9095417B2 (en) 2011-02-07 2015-08-04 Bioness Neuromodulation Ltd. Adjustable orthosis for electrical stimulation of a limb
US8790406B1 (en) 2011-04-01 2014-07-29 William D. Smith Systems and methods for performing spine surgery
WO2012155185A1 (en) 2011-05-13 2012-11-22 National Ict Australia Ltd Method and apparatus for measurement of neural response
US9974455B2 (en) 2011-05-13 2018-05-22 Saluda Medical Pty Ltd. Method and apparatus for estimating neural recruitment
CN103648583B (zh) 2011-05-13 2016-01-20 萨鲁达医疗有限公司 用于测量神经反应-a的方法和仪器
US8868217B2 (en) 2011-06-27 2014-10-21 Bioness Neuromodulation Ltd. Electrode for muscle stimulation
AU2012299061B2 (en) 2011-08-19 2017-02-23 Nuvasive, Inc. Surgical retractor system and methods of use
US9198765B1 (en) 2011-10-31 2015-12-01 Nuvasive, Inc. Expandable spinal fusion implants and related methods
WO2013112854A1 (en) * 2012-01-27 2013-08-01 T4 Analytics Llc Methods and systems for assessing muscle electrical activity in response to stimulation of a motor nerve
CA2862867A1 (en) * 2012-01-27 2013-08-01 T4 Analytics Llc Anesthesia monitoring systems and methods of monitoring anesthesia
US11259737B2 (en) 2012-11-06 2022-03-01 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring during spine surgery
US11877860B2 (en) 2012-11-06 2024-01-23 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring during spine surgery
US9757067B1 (en) 2012-11-09 2017-09-12 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring during spine surgery
JP6298825B2 (ja) 2012-12-05 2018-03-20 キム， ノ ウルＫＩＭ， Ｎｏ Ｅｕｌ 電極ユニットを有する電極ボイラ
US9757072B1 (en) 2013-02-11 2017-09-12 Nuvasive, Inc. Waveform marker placement algorithm for use in neurophysiologic monitoring
JP2016508400A (ja) * 2013-02-15 2016-03-22 アカシア・デザインズ・ベスローテン・フェンノートシャップ 医療用モニタリング・システムに使用する電極システム
EP2968910A4 (de) * 2013-03-15 2016-11-02 Emkinetics Inc Verfahren und vorrichtung zur transkutanen stimulation über den handflächen und fusssohlen
US10098585B2 (en) 2013-03-15 2018-10-16 Cadwell Laboratories, Inc. Neuromonitoring systems and methods
US9867985B2 (en) 2014-03-24 2018-01-16 Bioness Inc. Systems and apparatus for gait modulation and methods of use
US10420480B1 (en) 2014-09-16 2019-09-24 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring
EP4285985A3 (de) 2014-12-11 2024-01-17 Saluda Medical Pty Ltd Verfahren und vorrichtung zur rückkopplungssteuerung der nervenstimulation
AU2016245335B2 (en) 2015-04-09 2020-11-19 Saluda Medical Pty Ltd Electrode to nerve distance estimation
AU2017206723B2 (en) 2016-01-11 2021-11-25 Bioness Inc. Systems and apparatus for gait modulation and methods of use
US11179091B2 (en) 2016-06-24 2021-11-23 Saluda Medical Pty Ltd Neural stimulation for reduced artefact
KR20240051323A (ko) 2016-10-14 2024-04-19 브링크 디바이스, 엘엘씨 신경근 신호를 처리하는 장치, 방법, 및 시스템
US9808208B1 (en) * 2016-10-27 2017-11-07 Focal Wellness, Inc. Carpal tunnel infomatic monitor
US10188346B2 (en) 2016-10-27 2019-01-29 Focal Wellness, Inc. Cubital tunnel infomatic monitor
US9935395B1 (en) 2017-01-23 2018-04-03 Cadwell Laboratories, Inc. Mass connection plate for electrical connectors
US10758801B1 (en) 2017-02-11 2020-09-01 Focal Wellness, Inc. Method and system for proper kicking technique
US10874347B1 (en) 2017-03-02 2020-12-29 Focal Wellness, Inc. Multiple plane sensors
US11051737B2 (en) * 2017-05-19 2021-07-06 Ricoh Company, Ltd. Biomagnetic measurement method, biomagnetic measuring device, and biomagnetic measuring system
KR102432861B1 (ko) * 2017-06-15 2022-08-16 삼성전자주식회사 거리 측정을 위한 이미지 센서
USD837394S1 (en) 2017-07-11 2019-01-01 Neurometrix, Inc. Transcutaneous electrical nerve stimulation (TENS) device
USD857910S1 (en) 2017-09-21 2019-08-27 Neurometrix, Inc. Transcutaneous electrical nerve stimulation device
USD865986S1 (en) 2017-09-21 2019-11-05 Neurometrix, Inc. Transcutaneous electrical nerve stimulation device strap
CN112334184A (zh) 2018-04-27 2021-02-05 萨鲁达医疗有限公司 混合神经的神经刺激
US11992339B2 (en) 2018-05-04 2024-05-28 Cadwell Laboratories, Inc. Systems and methods for dynamic neurophysiological stimulation
US11253182B2 (en) 2018-05-04 2022-02-22 Cadwell Laboratories, Inc. Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation
USD861903S1 (en) 2018-05-15 2019-10-01 Neurometrix, Inc. Apparatus for transcutaneous electrical nerve stimulation
US11166648B2 (en) * 2018-05-24 2021-11-09 General Electric Company Method and system for estimating patient recovery time utilizing neuromuscular transmission measurements
US11443649B2 (en) 2018-06-29 2022-09-13 Cadwell Laboratories, Inc. Neurophysiological monitoring training simulator
US11612344B2 (en) 2018-11-02 2023-03-28 Biocircuit Technologies, Inc. Electrode-based systems and devices for interfacing with biological tissue and related methods
US11382564B2 (en) * 2018-12-28 2022-07-12 Jose Antonio Gamboa-Pinto Medical monitoring system with a foot diagnostic device
US11575822B2 (en) 2020-10-28 2023-02-07 Canon Kabushiki Kaisha Photoelectric conversion apparatus, photoelectric conversion system, and moving body

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3572322A (en) * 1968-10-11 1971-03-23 Hoffmann La Roche Transducer assembly
AT325196B (de) * 1971-12-01 1975-10-10 Rodler Ing Hans Gerät zur elektrodiagnose
US4213467A (en) * 1978-08-11 1980-07-22 Harvard College, President And Fellows Monitoring myoelectric signals
US4291705A (en) * 1979-09-10 1981-09-29 The Regents Of The University Of California Neuromuscular block monitor
US4807643A (en) * 1982-08-16 1989-02-28 University Of Iowa Research Foundation Digital electroneurometer
FI73878C (fi) * 1983-06-10 1987-12-10 Instrumentarium Oy Foerfarande foer vidareutveckling av nervmuskelanslutnings maetning.
US4811742A (en) * 1985-06-11 1989-03-14 Verimed, Inc. Proportional response electrical muscle stimulation
US4763666A (en) * 1986-04-22 1988-08-16 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Method and apparatus for determining the thermal sensitivity of the human peripheral nervous system
US5080099A (en) * 1988-08-26 1992-01-14 Cardiotronics, Inc. Multi-pad, multi-function electrode
US5099844A (en) * 1988-12-22 1992-03-31 Biofield Corp. Discriminant function analysis method and apparatus for disease diagnosis and screening
US5511553A (en) * 1989-02-15 1996-04-30 Segalowitz; Jacob Device-system and method for monitoring multiple physiological parameters (MMPP) continuously and simultaneously
US5050612A (en) * 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
DE3939790C1 (de) * 1989-12-01 1991-02-28 Draegerwerk Ag, 2400 Luebeck, De
NL9000983A (nl) * 1990-04-24 1991-11-18 Univ Nijmegen Inrichting en werkwijze voor het bepalen van de invloed van anesthetica op mens of dier.
US5143081A (en) * 1990-07-27 1992-09-01 New York University Randomized double pulse stimulus and paired event analysis
US5131401A (en) * 1990-09-10 1992-07-21 Axon Medical Inc. Method and apparatus for monitoring neuromuscular blockage
US5092344A (en) * 1990-11-19 1992-03-03 Lee Tzium Shou Remote indicator for stimulator
US5203330A (en) * 1991-02-26 1993-04-20 Vickers Plc Disposable electrodes for electromyography (EMG) and nerve conduction velocity (NCV) and kit containing same
US5255677A (en) * 1991-02-26 1993-10-26 Vickers Plc Disposable electrodes for electromyography (EMG) and nerve conduction velocity (NCV) and kit containing same
US5215100A (en) * 1991-04-29 1993-06-01 Occupational Preventive Diagnostic, Inc. Nerve condition monitoring system and electrode supporting structure
FR2698008A1 (fr) * 1992-11-13 1994-05-20 Mcadams Eric Dispositif multifonction à électrodes multiples et utilisation de ce dispositif.
US5379764A (en) * 1992-12-09 1995-01-10 Diasense, Inc. Non-invasive determination of analyte concentration in body of mammals
US5467768A (en) * 1993-03-17 1995-11-21 Nihon Koden Corporation Multi-purpose sensor
US5327902A (en) * 1993-05-14 1994-07-12 Lemmen Roger D Apparatus for use in nerve conduction studies
US5496363A (en) * 1993-06-02 1996-03-05 Minnesota Mining And Manufacturing Company Electrode and assembly
US5333618A (en) * 1993-06-30 1994-08-02 Gregory Lekhtman Portable self-contained instrument for the measurement of nerve resistance of a patient
US5560372A (en) * 1994-02-02 1996-10-01 Cory; Philip C. Non-invasive, peripheral nerve mapping device and method of use
US5540235A (en) * 1994-06-30 1996-07-30 Wilson; John R. Adaptor for neurophysiological monitoring with a personal computer
US6132386A (en) * 1997-07-01 2000-10-17 Neurometrix, Inc. Methods for the assessment of neuromuscular function by F-wave latency

Also Published As

Publication number Publication date
AU8157998A (en) 1999-01-25
US20090030337A1 (en) 2009-01-29
JP3657277B2 (ja) 2005-06-08
AU750315B2 (en) 2002-07-18
EP0993270A1 (de) 2000-04-19
US5976094A (en) 1999-11-02
US5851191A (en) 1998-12-22
JP2004261606A (ja) 2004-09-24
WO1999001064A1 (en) 1999-01-14
CA2295132C (en) 2004-09-14
DE69838549D1 (de) 2007-11-22
JP2001509721A (ja) 2001-07-24
CA2295132A1 (en) 1999-01-14
JP4324001B2 (ja) 2009-09-02
ATE375116T1 (de) 2007-10-15

Similar Documents

Publication Publication Date Title
EP0993270B1 (de) Gerät und verfahren zur beurteilung von neuromuskulärer funktion
US6379313B1 (en) Methods for the assessment of neuromuscular function by F-wave latency
US6146335A (en) Apparatus for methods for the assessment of neuromuscular function of the lower extremity
US6132387A (en) Neuromuscular electrode
US7628761B2 (en) Apparatus and method for performing nerve conduction studies with localization of evoked responses
US10293152B2 (en) Devices, systems, and methods for automated optimization of energy delivery
EP2615972B1 (de) Vorrichtung zur automatisierten messung der leitungsgeschwindigkeit und der amplitude der suralnerven
US6266558B1 (en) Apparatus and method for nerve conduction measurements with automatic setting of stimulus intensity
RU2126228C1 (ru) Способ определения состояния здоровья живого организма и устройство для реализации этого способа
US20150038873A1 (en) Apparatus and method for stimulator on-skin short detection
WO2007113271A2 (en) The band to measure the parameters of a human body and the system to analyze the parameters of a human body
Nivethitha et al. A Novel Wearable Device to Indicate Sciatic Nerve Pressure
JP2023530283A (ja) 浮腫の検出
WO2002065906A2 (en) Apparatus and method for performing nerve conduction studies with localization of evoked responses
EP3697289A1 (de) System für den einsatz am versorgungsort für die erkennung der körperlichen belastung verschiedener körperteile

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030813

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

RIN2 Information on inventor provided after grant (corrected)

Inventor name: GOZANI, SHAI, N.

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69838549

Country of ref document: DE

Date of ref document: 20071122

Kind code of ref document: P

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080110

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071010

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071010

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080121

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071010

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080310

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071010

EN Fr: translation not filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071010

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071010

26N No opposition filed

Effective date: 20080711

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080725

Ref country code: DE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080630

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080623

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071010

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071010

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080622

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20100630

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080630

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20110622

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110622